Pre-market
Loading markets…

Advertisement

Stocks

Why Hemostemix Inc stock is skyrocketing today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:HEM.V

Follow HEM

Photos provided by Pexels

Hemostemix Inc's stock surged by 7.69% in the last trading session, reflecting growing investor interest and confidence in the company.

In a notable turn of events, Hemostemix Inc (HEM.V) experienced a significant increase in its stock price, closing at CA$0.07 after gaining 7.69% in just one day. This uptick comes amidst ongoing financing activities that have captured the attention of investors.

Advertisement

Hemostemix Inc

HEM.V

Full stock page →

HEM.V

Hemostemix Inc

Source:WealthAwesomeWealthAwesome
↓ $0.03 (-29.41%)
120 day period
$0.04$0.07$0.09Mar 5Jun 10Sep 30

Market cap

$12.69M

52W high

$0.13

52W low

$0.04

1W change

-7.69%

Beta

0.67

Analyst Price Targets

Based on analyst covering HEM · as of Sep 17, 2026

📈

Wall Street analysts forecast HEM stock price to rise 1500.0% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$0.96

+1500.0% Upside

Current Price

C$0.06

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on HEM's historical volatility

HistoricalForecast68%95%
C$0.02C$0.06C$0.09C$0.13C$0.16C$0.19TodayApr 27Jul 16Sep 30Nov 12Dec 26Feb 7

30-Day Vol

84.1%

Annualized

90-Day Vol

111.5%

Annualized

Trend (90d)

+36.5%

Annualized drift

90d Mean

C$0.07

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$0.06C$0.05 – C$0.08
60 trading daysC$0.07C$0.04 – C$0.10
90 trading daysC$0.07C$0.04 – C$0.11

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should consider the implications of Hemostemix's recent financing activities and their potential to advance the company's clinical and regulatory initiatives.

Hemostemix Inc Stock Up 7.69% in One Day

Market capitalization reached CA$13.32 million, reflecting the company's growing valuation as investor interest increases.

Bull case

The recent private placements show that Hemostemix is successfully raising capital. This could strengthen its operations and support the development of its ACP-01 therapy, which might lead to revenue growth in the future.

Bear case

Even with this positive movement, Hemostemix's stock remains speculative. The limited media coverage might indicate potential risks that investors should be aware of.

Market Performance Overview

Advertisement

Hemostemix Inc's stock price climbed to CA$0.07, marking a 7.69% increase in the last trading session. This rise is significant for a company with a market cap of CA$13.32 million, indicating a growing interest from investors. The recent surge reflects the potential optimism surrounding the company's ongoing financing efforts.

Recent Financing Activities

The company has been active in securing funds through private placements, raising over CA$1 million in recent months. These funds are aimed at advancing Hemostemix's regulatory and clinical initiatives related to its ACP-01 therapy, which is expected to play a crucial role in the company's future growth. Investors are closely watching how these initiatives will unfold.

Looking Ahead

As Hemostemix continues to navigate its financing and development strategies, investors should remain vigilant. The stock's recent performance may indicate a positive trend, but the speculative nature of small-cap stocks like HEM.V means that potential investors should conduct thorough research and consider the associated risks.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 17, 2026
Last Updated: July 17, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement